EP1220898A2 - Hydanto ne-rac mase - Google Patents
Hydanto ne-rac maseInfo
- Publication number
- EP1220898A2 EP1220898A2 EP00964094A EP00964094A EP1220898A2 EP 1220898 A2 EP1220898 A2 EP 1220898A2 EP 00964094 A EP00964094 A EP 00964094A EP 00964094 A EP00964094 A EP 00964094A EP 1220898 A2 EP1220898 A2 EP 1220898A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- racemase
- hydantoin
- gene
- enzyme
- racemization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108010088443 hydantoin racemase Proteins 0.000 title description 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 23
- 108090001066 Racemases and epimerases Proteins 0.000 claims abstract description 20
- 102000004879 Racemases and epimerases Human genes 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 claims abstract description 10
- 230000008569 process Effects 0.000 claims abstract description 10
- 244000005700 microbiome Species 0.000 claims abstract description 7
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims abstract description 6
- 241000157908 Paenarthrobacter aurescens Species 0.000 claims abstract description 6
- 239000013598 vector Substances 0.000 claims abstract description 5
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000013612 plasmid Substances 0.000 abstract description 10
- 230000000694 effects Effects 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 239000000758 substrate Substances 0.000 description 13
- 230000006340 racemization Effects 0.000 description 12
- 239000000872 buffer Substances 0.000 description 9
- 150000001469 hydantoins Chemical class 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 5
- 101150074297 hyuA gene Proteins 0.000 description 5
- 238000012289 standard assay Methods 0.000 description 5
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 4
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 4
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000001952 enzyme assay Methods 0.000 description 3
- 229910000160 potassium phosphate Inorganic materials 0.000 description 3
- 235000011009 potassium phosphates Nutrition 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 2
- 102100036238 Dihydropyrimidinase Human genes 0.000 description 2
- 229940093740 amino acid and derivative Drugs 0.000 description 2
- -1 aromatic hydantoins Chemical class 0.000 description 2
- 230000002210 biocatalytic effect Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 108091022884 dihydropyrimidinase Proteins 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 2
- 229940091173 hydantoin Drugs 0.000 description 2
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 238000000711 polarimetry Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102100039398 C-X-C motif chemokine 2 Human genes 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 150000008574 D-amino acids Chemical class 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000012144 protein assay dye reagent concentrate Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
- C12P41/009—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving hydantoins or carbamoylamino compounds
Definitions
- the instant invention is directed to a hydantoin-racemase from Arthrobacter aurescens (DSM 3747, hyuA) .
- the chemical racemization of hydantoins proceeds via enolisation.
- the velocity depends on the electronic nature of the residue at the 5 '-position (Ware, Chem. Rev. (1950), 46, 403-470) but usually, the racemization is a very slow process.
- the racemization is a very slow process.
- at room temperature and pH 8.5 only about 10 % of -IMH is racemized to D-IMH in 20 hour (Syldatk et al . , "Biocatalytic production of amino acids and derivatives" (1992), Hanser publishers, New York, pp. 75-176) .
- the rate of racemization is increased by a very basic pH (>10) and high temperature (>80 °C) .
- Arthrobacter (Syldatk et al . , "Biocatalytic production of amino acids and derivatives” (1992), Hanser publishers, New York, pp. 75-176; Syldatk et al . , "Hydrolysis and formation of hydantoins” (1995), VCH Verlag, Weinheim, pp. 409-434) and a Pseudomonas species (Watabe et al . , J. Bacteriol . (1992a), 174, 3461-3466; Watabe et al . , J. Bacteriol. (1992b), 174, 7989-7995). Only the latter is also characterised in terms of nucleotide sequence and genetic organisation .
- an object of this invention to provide another rec-hydantoin-racemase, which is able to racemize hydantoins under physiological conditions with an acceptable rate for their implementation in a process for the production of enantiomerically enriched amino carboxylic acids on industrial scale.
- the racemase according to the invention can advantageously be incorporated in a large scale process for the production of enantiomerically enriched amino carboxylic acids.
- the feasibility of providing the racemase in a recombinant manner is the clue for acceptance of this process in view of economic efficiency.
- a gene (Seq. 3) encoding for the racemase according to the invention is protected.
- the gene with relation to the framework of this invention is seen as a group of genes comprising all possible genes encoding for the protein in question according to the degeneration of the genetic code.
- this invention encompasses plasmids, vectors and micro-organisms, which comprise the gene of instant invention.
- plasmids, vectors and micro-organisms which could advantageously be used to carry out the invention and are known to the skilled worker are incorporated herewith.
- those mentioned in Studier et al . , Methods Enzymol . 1990, 185, 61-69 or those presented in brochures of Novagen, Promega, New England Biolabs, Clontech or Gibco BRL are deemed to be suitable. More applicable plasmids, vectors can be found in:
- Denhardt, D. T. and Colasanti, J. A surey of vectors for regulating expression of cloned DNA in E. coli .
- Rodriguez, R.L. and Denhardt, D. T (eds) Vectors, Butterworth, Stoneham, MA, 1987, ppl79-204;
- primers useful for the amplification of the gene of the invention in a PCR are protected similarly.
- Primers which are feasible are for example: 51137 5' -AGAACATATGAGAATCCTCGTGATCAA-3 ' (Seq. 1)
- racemase of the invention is used in a process for the production of amino carboxylic acids or derivatives thereof.
- it is used according to the invention in a process for the production of enantiomerically enriched derivatives.
- the use is conducted in a covalent enzyme-membrane-reactor (DE19910691.6 ) or after non-covalent or covalent immobilisation to solid carriers (DE 197 033 14) .
- the gene was amplified by PCR from plasmid pAWl ⁇ using the primers S1137 and S1138 and placed under the control of a rhamnose promoter provided by the expression system pJOE2702.
- the resulting plasmid was designated pAW210 (Fig. 1) .
- the E. coli cells harbouring pAW210 exhibited specific hydantoin racemase activities up to a maximum of 60 U/mg in crude cell extracts (Fig. 2) .
- the racemase activity was determined in crude extracts by polarimetry using 3 M L-BH as substrate (Teves et al . , Fresenius ' J. Anal. Chem. 1999, 363, 738-743) .
- the plasmid pAW210 in E. coli JM109 was used for purification of the racemase.
- a two step procedure consisting of ammonium sulfate fractionation and MonoQ - anion exchange chromatography was accomplished as described down under.
- the racemase was purified 10-fold to homogeneity, with 35 % overall recovery (Tab. 1) .
- Protein was purified on MonoQ in 4 separate runs using 4 mg for each run.
- the specific activity of the purified enzyme was determined by standard enzyme assay with D-Benzylhydantoin as substrate at 313 U/mg. In potassium phosphate buffer, pH 7.0 with 25 % glycerol, the purified enzyme could be stored for at least 6 months at -20 °C without noticeable loss of activity.
- the matrix assisted laser desorption ionisation spectrum (MALDI) of the purified racemase gave a peak at a molecular mass of 25078.7. This is in good agreement with the calculated value of 25085 Da in contrast to the SDS-PAGE electrophoresis which gave a relative molecular mass of 31 kDa for the racemase monomer.
- MALDI matrix assisted laser desorption ionisation spectrum
- the relative molecular mass of the native enzyme was estimated to be approximately 170 kDa ⁇ 25. Due to the small subunit of 25 kDa and inaccuracy of the gel filtration method within this range the native enzyme is suggested to be either a hexamer, heptamer or octamer.
- Fig. 3-5 The effect of pH and temperature on the enzyme activity and stability are illustrated in Fig. 3-5.
- the pH optimum was determined between pH 8.0 and 9.0. Consequently, all standard assays were performed at pH 8.5.
- the optimum temperature for racemization of L-BH was around 55 °C, however the stability of the enzyme under assay conditions (Tris, pH 8.5) was only maintained up to 45 °C.
- the K M values of IMH and BH could not be determined due to the limited solubility of the substrates. Instead the initial velocities at different concentrations of L-MTEH were measured. The kinetic plot (Fig.6) showed that the racemase is inhibited by the substrate L-MTEH. Even at low substrate concentrations (> 5 mM) inhibition is observed.
- microorganism Arthrobacter aurescens used for the invention was desposited at Deutsche Sammlung fur
- E. coli JM109 (Yanisch-Perron et al . , Gene (1985), 33, 103-109) was used for cloning, sequencing and expression the hyuA gene from Arthrobacter aurescens DSM 3747 (Gro ⁇ et al . , Biotech. Tech. (1987), 2, 85-90) .
- E. coli strains were cultivated in 2xYT liquid broth or on 2xYT agar (Sambrook et al . , Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbour Laboratory Press, New York) . The media were supplemented with 100 ⁇ g/ml ampicillin to select plasmid carrying strains. The cultures were grown at 37°C, for hyuA expression the growth temperature was reduced to 30°C.
- the racemase gene was amplified by PCR using the primers S1137 (5'- AGAACATATGAGAATCCTCGTGATCAA-3 ' ) and S1138 (5'- AAAACTGCAGCTAGAGGTACTGCTTCTCTG-3 ' ) and pAW16 as template (Wilms et al . , J. Biotechnol . (1999), 68, 101-113).
- the fragment was inserted between the Ndel and Pstl sites of the expression vector pJOE2702 (Volff et al . , Mol . Microbiol. (1996), 21, 1037-1047) to create plasmid pAW210.
- Expression was induced by addition of 0.2 % rhamnose to cultures at an optical density of 0.3 at 600 nm. After 6 h, cells corresponding to OD 60 o of 10 were harvested, washed and resuspended in 1 ml desintegration buffer (0.07 M potassium phosphate, pH 7.0) and lysed by sonification (Ultrasonics sonicator, microtip, 2 x 30 s, duty cycle 50 % pulsed) . Clarified extracts were obtained by centrifugation at 14000 rpm for 10 min .
- the second precipitate obtained by centrifugation was resuspended in buffer A (10 mM potassium phosphate, pH 6.5) and applied to a MonoQ ® HR 5/5 column equilibrated in buffer A and eluted with a linear gradient of 0 to 1.0 M NaCl in buffer A.
- HyuA was eluted at a concentration of 0.37 M NaCl .
- Peak fractions were pooled and dialyzed against desintegration buffer, glycerol was added to a final concentration of 25 % and stored at -20 °C.
- Protein characterisation Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was done according to the method of Laemmli (Laemmli, Nature (1970), 227, 680-685) . Protein concentrations were determined by the method of Bradford (Bradford, Anal. Biochem. (1976), 72, 248-254) using the Biorad protein assay dye reagent concentrate. Standard curves were generated with bovine serum albumin. The M r of native protein was determined by gel filtration using superosel2HR column as described previously (Wil s et al . , J. Biotechnol .
- the column was equilibrated and eluted with buffer consisting of 0.1 M potassium phosphate and 0.1 M NaCl, pH 7.
- buffer consisting of 0.1 M potassium phosphate and 0.1 M NaCl, pH 7.
- the pH profile of the purified racemase was measured between the pH range 7.0 to 9.5 in Tris buffer.
- the substrate was dissolved in 0.1 M Tris, pH 3 at 45 °C using an ultrasonic waterbath. After cooling to room temperature, the pH was adjusted to the desired pH with sodium hydroxide and enzyme activity was determined using the standard assay.
- the reaction temperature optimum of purified racemase was determined using temperatures between 25 and 65 °C in the standard assay.
- the stability of the enzyme was measured after preincubation at temperatures between 25 and 70 °C for 15 minutes in the presence of desintegration buffer and 0.1 M Tris buffer, pH 8.5, respectively. The increased chemical racemization at high pH and temperatures, respectively, was considered.
- the effect of EDTA, DTT, HgCl 2 and iodoacetamid on HyuA was tested by incubation of respective substance (10 mM) and purified enzyme (12 ⁇ g) in desintegration buffer (final volume 20 ⁇ l) at 30°C. After 1 h specific activities were determined by the standard enzyme assay.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00964094A EP1220898A2 (fr) | 1999-09-27 | 2000-09-02 | Hydanto ne-rac mase |
DE20023437U DE20023437U1 (de) | 1999-09-27 | 2000-09-02 | Hydantoin-Racemase |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99118956 | 1999-09-27 | ||
EP99118956 | 1999-09-27 | ||
EP00964094A EP1220898A2 (fr) | 1999-09-27 | 2000-09-02 | Hydanto ne-rac mase |
PCT/EP2000/008580 WO2001023535A2 (fr) | 1999-09-27 | 2000-09-02 | Hydantoïne-racémase |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1220898A2 true EP1220898A2 (fr) | 2002-07-10 |
Family
ID=26075731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00964094A Withdrawn EP1220898A2 (fr) | 1999-09-27 | 2000-09-02 | Hydanto ne-rac mase |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1220898A2 (fr) |
DE (1) | DE20023437U1 (fr) |
-
2000
- 2000-09-02 EP EP00964094A patent/EP1220898A2/fr not_active Withdrawn
- 2000-09-02 DE DE20023437U patent/DE20023437U1/de not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
See references of WO0123535A2 * |
Also Published As
Publication number | Publication date |
---|---|
DE20023437U1 (de) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8460902B1 (en) | DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein, and method of producing optically active amino acid | |
Nanba et al. | Isolation of Agrobacterium sp. strain KNK712 that produces N-carbamyl-D-amino acid amidohydrolase, cloning of the gene for this enzyme, and properties of the enzyme | |
Wiese et al. | Hydantoin racemase from Arthrobacter aurescens DSM 3747: heterologous expression, purification and characterization | |
US7582454B2 (en) | 5-substituted hydantoin racemase, DNA coding for the racemase, and processes for producing optically active amino acids | |
US7393679B2 (en) | Whole cell catalyst | |
US7371555B2 (en) | Polypeptides having α-H-α-amino acid amide racemase activity and nucleic acids encoding the same | |
EP1558727B1 (fr) | Mutants destines a l'elaboration d'acides d-amines | |
JP3905575B2 (ja) | 新規の微生物、L−α−アミノ酸の製法並びに新規の微生物の突然変異株及び変体の培養法、カルバモイラーゼ及び/又はヒダントイナーゼ及び/又はヒダントインラセマーゼをコードする遺伝子の取得法及びカルバモイラーゼ及び/又はヒダントイナーゼ及び/又はヒダントインラセマーゼをコードする遺伝子の微生物又は細胞への挿入法 | |
US20050244936A1 (en) | Hydantoin-racemase | |
US7070963B2 (en) | Amidase from variovorax | |
US6800464B2 (en) | Arthrobacter D-carbamoylase and methods of preparing enantiomerically enriched D-amino acids | |
EP2128258B1 (fr) | Nouvelle amidase, gène pour celle-ci, vecteur, transformant et procédé de fabrication d'un amide d'acide carboxylique optiquement actif et d'un acide carboxylique optiquement actif à l'aide de l'un quelconque de ces éléments | |
EP1220898A2 (fr) | Hydanto ne-rac mase | |
KR20020087948A (ko) | 신규 d-아미노아실라제를 코딩하는 dna 및 그것을사용한 d-아미노산의 제조 방법 | |
US6902915B2 (en) | Heat-stable D-aminoacylase | |
US7629154B2 (en) | Deinococcus N-acylamino acid racemase and use of preparing L-amino acid | |
EP1057894B1 (fr) | Gènes d'estérase et leurs utilisations | |
JP4485734B2 (ja) | 5置換ヒダントインラセマーゼ、これをコードするdna、組み換えdna、形質転換された細胞および光学活性アミノ酸の製造方法 | |
KR100251524B1 (ko) | 고온성미생물바실러스속균주유래의내열성d-아미노산아미노트랜스퍼라아제를암호하는유전자및이를이용한d-아미노산아미노트랜스퍼라아제의제조방법 | |
US20030143677A1 (en) | Activated rec-D-hydantoinases | |
Kittelmann et al. | Isolation and characterization of N-acetyldehydroleucine acylase, a new enzyme from Zoogloea ramigera | |
JP2002330784A (ja) | 5置換ヒダントインラセマーゼ、これをコードするdna、組み換えdna、形質転換された細胞および光学活性アミノ酸の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020227 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: UNIVERSITAET STUTTGART Owner name: DEGUSSA AG |
|
17Q | First examination report despatched |
Effective date: 20030605 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040127 |